Remigius U. Agu

2.1k total citations
60 papers, 1.6k citations indexed

About

Remigius U. Agu is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Remigius U. Agu has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 15 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Remigius U. Agu's work include Advanced Drug Delivery Systems (16 papers), Drug Transport and Resistance Mechanisms (9 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Remigius U. Agu is often cited by papers focused on Advanced Drug Delivery Systems (16 papers), Drug Transport and Resistance Mechanisms (9 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Remigius U. Agu collaborates with scholars based in Canada, Belgium and United States. Remigius U. Agu's co-authors include Michael Ikechukwu Ugwoke, Renaat Kinget, Norbert Verbeke, Renaat Kinget, Mark Jorissen, Patrick Augustijns, Audra L. Stinchcomb, Satyanarayana Valiveti, Tom Willems and Emad Massoud and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Remigius U. Agu

56 papers receiving 1.5k citations

Peers

Countries citing papers authored by Remigius U. Agu

Since Specialization

Citations

This map shows the geographic impact of Remigius U. Agu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remigius U. Agu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remigius U. Agu more than expected).

Fields of papers citing papers by Remigius U. Agu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remigius U. Agu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remigius U. Agu. The network helps show where Remigius U. Agu may publish in the future.

Co-authorship network of co-authors of Remigius U. Agu

This figure shows the co-authorship network connecting the top 25 collaborators of Remigius U. Agu. A scholar is included among the top collaborators of Remigius U. Agu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remigius U. Agu. Remigius U. Agu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases 2021 ·(unknown), Pollen Yeung, Remigius U. Agu	0
2	Hemodynamic Assessment and In vivo Catabolism of Adenosine 5’-triphosphate in Doxorubicin or Isoproterenol-induced Cardiovascular Toxicity 2020 ·Drug Metabolism Letters ·Pollen Yeung, (unknown), (unknown), (unknown), Remigius U. Agu, Thomas Pulinilkunnil	1
3	Organic cation rhodamines for screening organic cation transporters in early stages of drug development 2016 ·Journal of Pharmacological and Toxicological Methods ·Malachy C. Ugwu, Angus Nnamdi Oli, Charles Okechukwu Esimone, Remigius U. Agu	11
4	Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-‘Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo 2016 ·Drug Metabolism Letters ·Pollen Yeung, (unknown), Remigius U. Agu	2
5	Potency and immunogenicity of bacillus calmette guerin (BCG) vaccines used in routine immunization programme in South-East, Nigeria 2014 ·African Journal of Pharmacy and Pharmacology ·Remigius U. Agu, (unknown), (unknown)	1
6	In vitroandin vivotesting methods for respiratory drug delivery 2010 ·Expert Opinion on Drug Delivery ·Remigius U. Agu, Michael Ikechukwu Ugwoke	38
7	Intranasal absorption of Δ9-tetrahydrocannabinol and WIN55,212-2 mesylate in rats 2006 ·European Journal of Pharmaceutics and Biopharmaceutics ·Satyanarayana Valiveti, Remigius U. Agu, Dana C. Hammell, Kalpana S. Paudel, (unknown), Daniel P. Wermeling, Audra L. Stinchcomb	13
8	Inhibition of calpain-mediated cell death by a novel peptide inhibitor 2006 ·Experimental Neurology ·(unknown), (unknown), Bert C. Lynn, Remigius U. Agu, Audra L. Stinchcomb, Shaomeng Wang, (unknown), Ronald D. Guttmann	9
9	Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium 2004 ·Peptides ·Remigius U. Agu, Hoang Vu Dang, Mark Jorissen, Renaat Kinget, Norbert Verbeke	17
10	Intranasal Delivery of Recombinant Human Parathyroid Hormone [hPTH (1–34)], Teriparatide in Rats 2004 ·Endocrine Research ·Remigius U. Agu, Satyanarayana Valiveti, (unknown), Mitchell Klausner, Patrick Hayden, Daniel P. Wermeling, Audra L. Stinchcomb	18
11	Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium 2003 ·European Journal of Pharmaceutics and Biopharmaceutics ·Remigius U. Agu, Mark Jorissen, Tom Willems, Renaat Kinget, Norbert Verbeke	10
12	In Vitro Polarized Transport of L-Phenylalanine in Human Nasal Epithelium and Partial Characterization of the Amino Acid Transporters Involved 2003 ·Pharmaceutical Research ·Remigius U. Agu, (unknown), Mark Jorissen, Tom Willems, Sandy Vandoninck, Johan Van Lint, (unknown), Renaat Kinget, Norbert Verbeke	11
13	Derivatized and fibrillar collagen films as scaffold for nasal epithelial cells to study nasal drug absorption in vitro 2002 ·Lirias (KU Leuven) ·Remigius U. Agu, Mark Jorissen, Tom Willems, Peter de Witte, Renaat Kinget, N. Verbeke	5
14	Alternatives to in vivo nasal toxicological screening for nasally-administered drugs 2002 ·Lirias (KU Leuven) ·Remigius U. Agu, Mark Jorissen, Renaat Kinget, Norbert Verbeke, Patrick Augustijns	7
15	Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium 2002 ·International Journal of Pharmaceutics ·Remigius U. Agu, (unknown), Mark Jorissen, Tom Willems, Renaat Kinget, Norbert Verbeke	28
16	Safety assessment of selected cyclodextrins — effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis 2000 ·International Journal of Pharmaceutics ·Remigius U. Agu, Mark Jorissen, Tom Willems, Guy Van den Mooter, Renaat Kinget, Norbert Verbeke, Patrick Augustijns	35
17	Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa 2000 ·European Journal of Pharmaceutical Sciences ·Michael Ikechukwu Ugwoke, Remigius U. Agu, Mark Jorissen, Patrick Augustijns, Raf Sciot, Norbert Verbeke, Renaat Kinget	32
18	Toxicological investigations of the effects carboxymethylcellulose on ciliary beat frequency of human nasal epithelial cells in primary suspension culture and in vivo on rabbit nasal mucosa 2000 ·International Journal of Pharmaceutics ·Michael Ikechukwu Ugwoke, Remigius U. Agu, Mark Jorissen, Patrick Augustijns, Raf Sciot, Norbert Verbeke, Renaat Kinget	26
19	Human nasal epithelial cell culture system to screen cilio-toxicity of pharmaceutical compounds in vitro 1999 ·Journal of Pharmaceutical Sciences ·Patrick Augustijns, Remigius U. Agu, Tom Willems, Guy Van den Mooter, Renaat Kinget, Mark Jorissen	1
20	Effects of Pharmaceutical Compounds on Ciliary Beating in Human Nasal Epithelial Cells: A Comparative Study of Cell Culture Models 1999 ·Pharmaceutical Research ·Remigius U. Agu, Mark Jorissen, Tom Willems, Guy Van den Mooter, Renaat Kinget, Patrick Augustijns	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact